Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
20 Mar - 04 Apr 2018
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2018
Report date:
2018

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Version / remarks:
adopted in 1987
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.3 (Acute Toxicity (Dermal))
Version / remarks:
adopted in 2008
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Schwabach, Germany
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Reference substance name:
Reaction product of C16-18 (even numbered) alcohols with reaction products of 1,3,5-Triazine, 2,4,6,-triamine, polymer with formaldehyde, methylated
EC Number:
947-918-6
Molecular formula:
not applicable, UVCB substance.
IUPAC Name:
Reaction product of C16-18 (even numbered) alcohols with reaction products of 1,3,5-Triazine, 2,4,6,-triamine, polymer with formaldehyde, methylated
Test material form:
solid

Test animals

Species:
rat
Strain:
Wistar
Remarks:
Crl:WI(Han)
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River, Sulzfeld, Germany
- Females nulliparous and non-pregnant: yes
- Age at study initiation: 9 - 10 weeks (males range) and 12 - 13 weeks (females range)
- Weight at study initiation: 250 - 261 g (males range) and 214 - 233 g (females range)
- Housing: individually in IVC cages type III H, polysulphone cages on Altromin saw fibre bedding
- Diet: Altromin 1324 maintenance diet for rats and mice, ad libitum
- Water: tap water, sulphur acidified to a pH value of approximately 2.8, ad libitum
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 55 ± 10
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Type of coverage:
semiocclusive
Vehicle:
other: The test item was moistened with sterile water.
Details on dermal exposure:
TEST SITE
- Area of exposure: dorsal area of the trunk
- % coverage: 10%
- Type of wrap if used: The test item was held in contact with the skin by a semi-occlusive dressing consisting of a porous gauze and non-irritating tape that was fixed with an additional dressing.

REMOVAL OF TEST SUBSTANCE
- Washing: Residual test item was removed using sterile water.
- Time after start of exposure: 24 h

TEST MATERIAL
- Amount applied: 2000 mg/kg bw
- For solids, paste formed: yes; test item was moistened with sterile water


Duration of exposure:
24 h
Doses:
2000 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: A careful clinical examination was made at least once during the first 30 min post-dose and several times during the first 4 h post-dose. Thereafter, the animals were observed for clinical signs once daily until the end of the observation period.The animals were weighed on day 1 (prior to the application) and on days 8 and 15.
- Necropsy of survivors performed: yes
- Other examinations performed: Signs of erythema and oedema were assessed using the scoring system (Table 2) laid down in OECD Guideline 404. Cageside observations included changes in the skin and fur, eyes and mucous membranes. Also respiratory, circulatory, autonomic and central nervous systems and somatomotor activity and behaviour pattern were examined. Attention was directed to observations of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma.

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
No mortality was oberved during the study period.
Clinical signs:
other: No signs of acute systemic toxicity or signs of local dermal irritation were observed in any animal.
Gross pathology:
No specific gross pathological changes were recorded for any animal.
Other findings:
All animals treated with the test item showed a yellow discolouration at the application site during the whole observation period, due to residual test item.

Any other information on results incl. tables

Table 1. Absolute body weights (bw) in g and body weight change in %

Dose: 2000 mg/kg body weight
Animal No. / Sex g Day 1 g Day 8 g Day 15 % Day 1-15
21 / male 261 289 324 24
22 / male 250 276 305 22
23 / male 260 291 325 25
24 / male 255 280 303 19
25 / male 258 293 328 27
26 / female 223 220 229 3
27 / female 233 220 230 -1
28 / female 214 224 231 8
29 / female 215 212 216 0
30 / female 217 212 217 0

Applicant's summary and conclusion

Interpretation of results:
other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008
Conclusions:
In this acute dermal toxicity study a LD50 value > 2000 mg/kg bw in male and female rats was found.